• Assert a
successful preemption defense and manage parallel plaintiff claims in a post-Mensing world;
• Impeach witness credibility and dilute the plaintiff witness' opinion via a Daubert challenge;
• Adhere to strict litigation budgets set by counsel in this tight economy;
• Utilize the learned intermediary doctrine as a key defense when members of the sales team are forced to testify;
• Manage cumbersome global discovery demands;
• Establish in cross-examination that product risks were contained on the label and were not withheld by the company; and
• Mitigate the risks of shareholder derivative litigation stemming from recall and adverse event activity.
• Asserting a
successful preemption defense and managing parallel plaintiff claims in a post-Mensing world;
• Industry keynote address;
• Preparing your sales and compliance teams for their day in court;
• Managing litigation in a tough economy: Containing litigation costs with a restricted budget;
• Operating in an aggressive enforcement climate: Proactive litigation strategies for responding to government investigations and thwarting individual accountability (breakout session);
• Class action litigation trends & innovations: Emerging theories of liability, certification, and new developments (breakout session);
• Dissecting evolving claims against generic drugs and the naming of brand manufacturers as co-defendants (breakout session);
• Controlling the witness message: Using medical records and testimony to demonstrate that the company did what was best for patient safety (breakout session);
• Exploring device manufacturers' duty to train physicians on the effective use of a particular device (breakout session);
• Preparing and defending Daubert challenges to causation expert testimony: Utilizing the theory in practice (breakout session);
• Implementing best practices for bellwether trial selection in mass tort litigation;
• View from the Bench: Current judicial views on pharmaceutical and medical device litigation;
• Defending new and emerging claims rising out of shareholder derivative lawsuits against life sciences companies;
• Analyzing products liability trends outside the U.S. -- Coordinating litigation efforts across international jurisdictions; and
• Taking the social media plunge: Engaging customers online while minimizing the inherent litigation risks of viral communication.
In addition, a pre-conference jury selection session on "Novel Strategies, Tactics and Ethical Considerations for Selecting the Right Jury" will be offered from 9:00 am to 12:30 pm on December 3, 2012, and a pre-conference group meet-up will be held from 3:00 to 5:00 pm on December 3, 2012. A post-conference business development master class entitled "In-House Counsel Perspectives on Selecting and Evaluating Outside Counsel" will be offered from 3:30 pm to 5:30 pm on December 5, 2012.
The agenda for the Drug and Medical Device Litigation conference can be found here. A complete brochure for this conference, including an agenda, detailed descriptions of conference sessions, list of speakers, and registration form can be obtained here.
The registration fee for the conference is $2,695 (conference and group meet-up), $3,295 (conference, group meet-up, and workshop or master class), or $3,695 (conference, group meet-up, workshop, and master class). Those registering by September 27, 2012 will receive a $500 discount, and those registering by November 2, 2012 will receive a $200 discount. Patent Docs readers who reference the discount code "PD 200" will receive $200 off the current price tier when registering. Those interested in registering for the conference can do so here, by calling 1-888-224-2480, by faxing a registration form to 1-877-927-1563, or by e-mailing [email protected]
Patent Docs is a media partner of the Drug and Medical Device Litigation conference.